Emilie van Lingen

Faecal microbiota transplantation for <i>Clostridioides difficile</i> infection: Four years’ experience of the Netherlands Donor Feces Bank

Elisabeth M. Terveer, Karuna E.W. Vendrik, Rogier E. Ooijevaar et al. · United European Gastroenterology Journal · 2020 · 66 citations · Full text

Medicine, Infectious Diseases, Microbiology +17

Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study

Karuna E.W. Vendrik, Elisabeth M. Terveer, Ed J. Kuijper et al. · The Lancet Infectious Diseases · 2020 · 47 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study

Emilie van Lingen, Sam Nooij, Elisabeth M. Terveer et al. · Journal of Crohn s and Colitis · 2024 · 23 citations · Full text

Life Sciences, Immunology, Inflammation +15

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent <i>Clostridioides difficile</i> infection in patients with inflammatory bowel disease

Emilie van Lingen, Simon Mark Dahl Baunwall, Simone Lieberknecht et al. · Therapeutic Advances in Gastroenterology · 2023 · 18 citations · Full text

Life Sciences, Immunology, Microbiology +15

Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up

Emilie van Lingen, ME Tushuizen, Maurice Steenhuis et al. · International Journal of Colorectal Disease · 2021 · 12 citations · Full text

Medicine, Internal Medicine, Pathology +17